This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Mcgill University. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Rami N Hannoush: Innovator in Oligonucleotide Agents
Introduction
Rami N Hannoush is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of oligonucleotide agents that target viral infections. His work is crucial in the ongoing battle against retroviruses.
Latest Patents
Hannoush holds a patent titled "Compositions and methods for inhibiting RNase H activity of retroviral reverse transcriptase." This invention relates to oligonucleotide agents that inhibit RNase H activity of a retrovirus reverse transcriptase. These agents are useful for inhibiting retrovirus proliferation and preventing or treating retrovirus infections. He has 1 patent to his name.
Career Highlights
Rami N Hannoush is affiliated with McGill University, where he continues to engage in innovative research. His work has implications for therapeutic strategies against retroviral diseases, showcasing his commitment to advancing medical science.
Collaborations
Hannoush has collaborated with esteemed colleagues such as Masad Jose Damha and Kyung-Lyum Min. These partnerships enhance the research environment and contribute to the development of groundbreaking solutions in the field.
Conclusion
Rami N Hannoush is a dedicated inventor whose work in oligonucleotide agents is paving the way for new treatments against retroviral infections. His contributions to biotechnology are invaluable and reflect his commitment to improving public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile